חוב כולל של החברה: microbotmedical.com (MBOT)

This chart of the cost of debt for Microbot Medical Inc. (MBOT) currently stands at 0.00. Microbot Medical Inc. (MBOT) develops robotic systems for microsurgery, planning to monetize the sale and servicing of systems for endovascular interventions. As the business remains in the pre-commercial stage, scaling profits is currently impossible, while the costs of launching clinical trials remain extremely high.

A defensive portfolio requires strict leverage control to minimize bankruptcy risks. This metric aggregates all long-term and short-term borrowings, reflecting the total cost of external financing. For Microbot Medical Inc. (MBOT), such resources are critical for the development of Liberty microrobots in collaboration with cardiology centers. An optimal balance of debt capital ensures a technological leap without compromising stability. By analyzing the current level of liabilities, an investor assesses the issuer's financial autonomy.